# Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

> **NCT04781387** · PHASE2 · COMPLETED · sponsor: **Crestone, Inc** · enrollment: 43 (actual)

## Conditions studied

- Clostridioides Difficile Infection

## Interventions

- **DRUG:** CRS3123
- **DRUG:** Active Comparator

## Key facts

- **NCT ID:** NCT04781387
- **Lead sponsor:** Crestone, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-05
- **Primary completion:** 2024-04-16
- **Final completion:** 2024-04-16
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04781387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04781387, "Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04781387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*